Central nervous system metastases of lung adenocarcinoma harboring EGFR-activating mutations: survival results from a multidisciplinary approach, including EGFR-TKIs
Objectives: Central nervous system (CNS) metastases are frequent in advanced lung adenocarcinomas harboring EGFR-activating mutations. However, the best treatment approach must be defined. We aimed to evaluate the effectiveness of a multidisciplinary approach for CNS metastases in patient...
Saved in:
| Main Authors: | Guilherme Harada, Renata Rodrigues da Cunha Colombo Bonadio, Guilherme Nader Marta, Debora Zachello Recchimuzzi, Gilberto de Castro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia
2020-01-01
|
| Series: | Brazilian Journal of Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.5935/2526-8732.20200011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of osimertinib in advanced T790M-positive NSCLC after progression to prior EGFR-TKI: real world data from a Brazilian cohort
by: Luiz Henrique Araujo, et al.
Published: (2020-01-01) -
Prognostic impact of <i>EGFR</i> and <i>KRAS</i> mutations in lung cancer survival during pre-tki era: the real scenario at a cancer public center of reference in Brazil
by: Thais Abreu Almeida, et al.
Published: (2019-01-01) -
Neuregulin-1, or NRG 1, is a powerful cardiomyocyte proliferator that impacts the circulatory system. Endothelial cells in the bloodstream secrete and release it. It is essential for the development, proliferation, differentiation, apoptosis, and other ca
by: Wafaa Sh. Al – Zuhairi Sh. Al – Zuhairi, et al.
Published: (2024-10-01) -
Disrupted neuregulin 1-ErbB4 signaling: Consequences of prenatal morphine exposure in rat pups and molecular gateway to neurological impairment
by: Samira Khayat, et al.
Published: (2024-12-01) -
ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01)